A Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Completed
Incyte Corporation
Phase 2
The purpose of this study is to evaluate the safety of INCB054707 over an 8-week treatment
period in men and women with moderate to severe hidradenitis suppurativa.
To Assess the Efficacy and Safety of INCB054707 in Participants With Hidradenitis Suppurativa
Active, not recruiting
Incyte Corporation
Phase 2
To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis
suppurativa over a 16-week placebo-controlled treatment period followed by a 36 -week
open-label extension period.
A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo
Recruiting
Incyte Corporation
Phase 2
The purpose of this study is to evaluate the efficacy and safety of INCB054707 over a 24-week
placebo-controlled double-blind treatment period, followed by a 28-week double-blind
extension period in participants with nonsegmental vitiligo.
A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis
Recruiting
Incyte Corporation
Phase 2
The purpose of this study is to evaluate the efficacy and safety of INCB054707 in
participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment
period, followed by a 24 -week single blind extension period.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
